Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Nov;22(5):613–615. doi: 10.1111/j.1365-2125.1986.tb02944.x

Salivary concentrations of pirmenol as a possible cause of unpleasant taste.

B F Johnson, V Shekar, T Woodman, A T Canada
PMCID: PMC1401175  PMID: 2431704

Abstract

Salivary concentrations of the anti-arrhythmic, pirmenol, were compared with plasma concentrations in six patients. Group mean salivary values tended to be higher despite high plasma protein binding, suggesting the possibility of an active transport process. The observed salivary concentrations are reasonably close to those detectable in healthy volunteers as tasting unpleasant.

Full text

PDF
613

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borzelleca J. F., Cherrick H. M. The excretion of drugs in saliva. Antibiotics. J Oral Ther Pharmacol. 1965 Nov;2(3):180–187. [PubMed] [Google Scholar]
  2. Dawes C. P., Kendall M. J., John V. A. Comparison of plasma and saliva levels of metoprolol and oxprenolol. Br J Clin Pharmacol. 1978 Mar;5(3):217–221. doi: 10.1111/j.1365-2125.1978.tb01627.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Groth U., Prellwitz W., Jähnchen E. Estimation of pharmacokinetic parameters of lithium from saliva and urine. Clin Pharmacol Ther. 1974 Sep;16(3):490–498. doi: 10.1002/cpt1974163part1490. [DOI] [PubMed] [Google Scholar]
  4. Hammill S. C., Shand D. G., Routledge P. A., Hindman M. C., Baker J. T., Pritchett E. L. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation. 1982 Feb;65(2):369–375. doi: 10.1161/01.cir.65.2.369. [DOI] [PubMed] [Google Scholar]
  5. Koup J. R., Jusko W. J., Goldfarb A. L. pH-dependent secretion of procainamide into saliva. J Pharm Sci. 1975 Dec;64(12):2008–2010. doi: 10.1002/jps.2600641226. [DOI] [PubMed] [Google Scholar]
  6. Reder R. F., Danilo P., Jr, Rosen M. R. Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers. Eur J Pharmacol. 1980 Feb;61(4):321–333. doi: 10.1016/0014-2999(80)90071-0. [DOI] [PubMed] [Google Scholar]
  7. Sanders S. W., Nappi J. M., Foltz R. L., Lutz J. R., Anderson J. L. Disposition of intravenous pirmenol. J Clin Pharmacol. 1983 Feb-Mar;23(2-3):113–122. doi: 10.1002/j.1552-4604.1983.tb02713.x. [DOI] [PubMed] [Google Scholar]
  8. Steffe T. J., Mertz T. E., Hastings S. G., Potoczak R. E., Kaplan H. R. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent. J Pharmacol Exp Ther. 1980 Jul;214(1):50–57. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES